Your account is not claimed yet. You can sign up with ORCID to claim your account.

Xiang-Lin Yuan (Xianglin Yuan)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Venues

BMC cancer

Oxidative medicine and cellular longevity

Cancer research

Journal of healthcare engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Chen, Mu Yang, Lu Wang, Yuan Wang, Jingyao Tu, Xiao Zhou, Xiang-Lin Yuan
Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma. BMC cancer 23 (1) (2023)
Meng Jin, Zhihua Wang, Can Chen, Yongbiao Huang, Huixian Zhang, Bingliang Chen, Guoda Song, Dong Zhao, Limin Duan, Wei Liu, Haizhen Yang, Fang Yue, Peijun Liu, Xiang-Lin Yuan, Qian Chu, Jianbo Tian, Ke Hu
Genome-wide splicing QTL analysis identifies causal risk variants for non-small cell lung cancer. Cancer research (2023)
Xinyi Chen, Mu Yang, Jingyao Tu, Xiang-Lin Yuan
Integrated bioinformatics and validation reveal SOX12 as potential biomarker in colon adenocarcinoma based on an immune infiltration-related ceRNA network. Journal of cancer research and clinical oncology (2023)
Xinyi Chen, Mu Yang, Lu Wang, Yuan Wang, Jingyao Tu, Xiao Zhou, Xiang-Lin Yuan
Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma. BMC cancer 23 (1) (2023)
Chaofan Liu, Xi Wang, Wan Qin, Jingyao Tu, Chunya Li, Weiheng Zhao, Li Ma, Bo Liu, Hong Qiu, Xiang-Lin Yuan
Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer. Cancer communications (London, England) (2023)
Xinyi Chen, Mu Yang, Lu Wang, Yuan Wang, Jingyao Tu, Xiao Zhou, Xiang-Lin Yuan
Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma. BMC cancer 23 (1) (2023)
Shuangshuang Mao, Zuhua Chen, Yingying Wu, Huihua Xiong, Xiang-Lin Yuan
Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma. Journal of oncology 2022 (2022)
Shanshan Huang, Yongbiao Huang, Wanling Lin, Lei Wang, Yang Yang, Piao Li, Lei Xiao, Yuan Chen, Qian Chu, Xiang-Lin Yuan
Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota Disorder. Oxidative medicine and cellular longevity 2022 (2022)
Xin Pan, Minxiao Yi, Chaofan Liu, Yu Jin, Zhihua Wang, Guangyuan Hu, Xiang-Lin Yuan
Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model. Bioengineered 13 (2) (2022)
Feng-Hua Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Yingying Shi, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Lingyan Xiao, Qian Li, Yongbiao Huang, Zhijie Fan, Li Ma, Zhihua Wang, Xiang-Lin Yuan
Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma. Journal of healthcare engineering 2022 (2022)

Xiang-Lin Yuan.css-eqlu8i{font-size:small;padding-left:4px;} (Xianglin Yuan)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiang-Lin Yuan (Xianglin Yuan)